» Articles » PMID: 25325969

The Detection of Glycosaminoglycans in Pancreatic Islets and Lymphoid Tissues

Overview
Specialty Molecular Biology
Date 2014 Oct 19
PMID 25325969
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

In this chapter, we describe the detection of the glycosaminoglycans hyaluronan and heparan sulfate in pancreatic islets and lymphoid tissues. The identification of hyaluronan in tissues is achieved by utilizing a highly specific hyaluronan binding protein (HABP) probe that interacts with hyaluronan in tissue sections. The HABP probe is prepared by enzymatic digestion of the chondroitin sulfate proteoglycan aggrecan which is present in bovine nasal cartilage, and is then biotinylated in the presence of bound hyaluronan and the link protein. Hyaluronan is then removed by gel filtration chromatography. The biotinylated HABP-link protein complex is applied to tissue sections and binding of the complex to tissue hyaluronan is visualized by enzymatic precipitation of chromogenic substrates. To determine hyaluronan content in tissues, tissues are first proteolytically digested to release hyaluronan from the macromolecular complexes that this molecule forms with other extracellular matrix constituents. Digested tissue is then incubated with HABP. The hyaluronan-HABP complexes are extracted and the hyaluronan concentration in the tissue is determined using an ELISA-like assay. Heparan sulfate is identified in mouse tissues by Alcian blue histochemistry and indirect immunohistochemistry. In human tissues, heparan sulfate is best detected by indirect immunohistochemistry using a specific anti-heparan sulfate monoclonal antibody. A biotinylated secondary antibody is then applied in conjunction with streptavidin-peroxidase and its binding to the anti-heparan sulfate antibody is visualized by enzymatic precipitation of chromogenic substrates.

Citing Articles

Heparanase 2 (Hpa2)- a new player essential for pancreatic acinar cell differentiation.

Kayal Y, Barash U, Naroditsky I, Ilan N, Vlodavsky I Cell Death Dis. 2023; 14(7):465.

PMID: 37491420 PMC: 10368643. DOI: 10.1038/s41419-023-05990-y.


The Alterations and Roles of Glycosaminoglycans in Human Diseases.

Wang Q, Chi L Polymers (Basel). 2022; 14(22).

PMID: 36433141 PMC: 9694910. DOI: 10.3390/polym14225014.


High-molecular weight hyaluronan attenuates tubulointerstitial scarring in kidney injury.

Wang X, Balaji S, Steen E, Blum A, Li H, Chan C JCI Insight. 2020; 5(12).

PMID: 32396531 PMC: 7406305. DOI: 10.1172/jci.insight.136345.


Extracellular matrix molecules and their potential contribution to the function of transplanted pancreatic islets.

Alberto Llacua L, Faas M, de Vos P Diabetologia. 2018; 61(6):1261-1272.

PMID: 29306997 PMC: 6449002. DOI: 10.1007/s00125-017-4524-8.


The Content and Size of Hyaluronan in Biological Fluids and Tissues.

Cowman M, Lee H, Schwertfeger K, McCarthy J, Turley E Front Immunol. 2015; 6:261.

PMID: 26082778 PMC: 4451640. DOI: 10.3389/fimmu.2015.00261.


References
1.
Tan K, McGrouther D, Day A, Milner C, Bayat A . Characterization of hyaluronan and TSG-6 in skin scarring: differential distribution in keloid scars, normal scars and unscarred skin. J Eur Acad Dermatol Venereol. 2010; 25(3):317-27. PMC: 3504979. DOI: 10.1111/j.1468-3083.2010.03792.x. View

2.
Ripellino J, Bailo M, Margolis R, Margolis R . Light and electron microscopic studies on the localization of hyaluronic acid in developing rat cerebellum. J Cell Biol. 1988; 106(3):845-55. PMC: 2115103. DOI: 10.1083/jcb.106.3.845. View

3.
Parkkinen J, Hakkinen T, Savolainen S, Wang C, Tammi R, Agren U . Distribution of hyaluronan in articular cartilage as probed by a biotinylated binding region of aggrecan. Histochem Cell Biol. 1996; 105(3):187-94. DOI: 10.1007/BF01462291. View

4.
Kramer R, Rosen S, McDonald K . Basement-membrane components associated with the extracellular matrix of the lymph node. Cell Tissue Res. 1988; 252(2):367-75. DOI: 10.1007/BF00214379. View

5.
Boregowda R, Appaiah H, Siddaiah M, Kumarswamy S, Sunila S, Thimmaiah K . Expression of hyaluronan in human tumor progression. J Carcinog. 2006; 5:2. PMC: 1360664. DOI: 10.1186/1477-3163-5-2. View